Group One Trading
CRBP icon

Group One Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Group One Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,300
Closed -$43.1K – 7808
2025
Q4 		$43.1K Sell
5,300
-2,800
-35% -$34.6K ﹤0.01% 5723
2025
Q3 		$102K Buy
8,100
+4,500
+125% +$42.8K ﹤0.01% 5326
2025
Q2 		$24.8K Hold
3,600
– – ﹤0.01% 6116
2025
Q1 		$19.1K Sell
3,600
-8,700
-71% -$76.8K ﹤0.01% 5839
2024
Q4 		$145K Sell
12,300
-460,900
-97% -$7.73M ﹤0.01% 4201
2024
Q3 		$9.76M Buy
473,200
+471,600
+29,475% +$24.1M 0.03% 634
2024
Q2 		$72.4K Buy
+1,600
New +$67.3K ﹤0.01% 4226
2024
Q1 		– Sell
-200
Closed -$1.21K – 7169
2023
Q4 		$1.21K Hold
200
– – ﹤0.01% 6954
2023
Q3 		$1.35K Hold
200
– – ﹤0.01% 7155
2023
Q2 		$1.57K Hold
200
– – ﹤0.01% 7159
2023
Q1 		$1.45K Sell
200
-557
-74% -$2.44K ﹤0.01% 6689
2022
Q4 		$2.51K Sell
757
-3
-0.4% -$12 ﹤0.01% 6584
2022
Q3 		$4K Hold
760
– – ﹤0.01% 6903
2022
Q2 		$6K Sell
760
-167
-18% -$1.61K ﹤0.01% 6983
2022
Q1 		$15K Sell
927
-2,433
-72% -$32.2K ﹤0.01% 6941
2021
Q4 		$62K Sell
3,360
-1,973
-37% -$53.4K ﹤0.01% 6149
2021
Q3 		$163K Sell
5,333
-687
-11% -$27.1K ﹤0.01% 5376
2021
Q2 		$331K Sell
6,020
-683
-10% -$37.9K ﹤0.01% 4680
2021
Q1 		$396K Sell
6,703
-4,090
-38% -$269K ﹤0.01% 4305
2020
Q4 		$405K Sell
10,793
-2,960
-22% -$111K ﹤0.01% 3461
2020
Q3 		$743K Buy
13,753
+4,026
+41% +$729K ﹤0.01% 2473
2020
Q2 		$2.45M Buy
9,727
+1,610
+20% +$325K 0.01% 1321
2020
Q1 		$1.28M Buy
8,117
+7,974
+5,576% +$1.35M 0.01% 1340
2019
Q4 		$23K Sell
143
-57
-29% -$8.42K ﹤0.01% 4316
2019
Q3 		$29K Sell
200
-220
-52% -$38.3K ﹤0.01% 4219
2019
Q2 		$87K Sell
420
-437
-51% -$93.6K ﹤0.01% 3462
2019
Q1 		$179K Sell
857
-463
-35% -$102K ﹤0.01% 2784
2018
Q4 		$231K Buy
1,320
+373
+39% +$74.4K ﹤0.01% 2573
2018
Q3 		$214K Buy
947
+720
+317% +$116K ﹤0.01% 2968
2018
Q2 		$34K Buy
227
+40
+21% +$7.27K ﹤0.01% 4145
2018
Q1 		$34K Sell
187
-810
-81% -$182K ﹤0.01% 3837
2017
Q4 		$212K Sell
997
-4,660
-82% -$997K ﹤0.01% 2887
2017
Q3 		$1.21M Sell
5,657
-3,366
-37% -$659K 0.01% 1415
2017
Q2 		$1.71M Sell
9,023
-7,760
-46% -$1.52M 0.02% 1053
2017
Q1 		$4.15M Buy
16,783
+15,816
+1,636% +$3.88M 0.05% 482
2016
Q4 		$245K Sell
967
-2,410
-71% -$552K ﹤0.01% 2281
2016
Q3 		$688K Buy
+3,377
New +$420K 0.01% 1569

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's CRBP Position: Q1 2026 in Review

Group One Trading increased its Corbus Pharmaceuticals (CRBP) stake by 9.3% in Q1 2026, buying an estimated $5.15K and bringing the position to 7,198 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5043.

Group One Trading first reported a position in CRBP in Q2 2017 and has held it in 32 quarters since. The position peaked at $966K in Q3 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Group One Trading held 7,198 shares of Corbus Pharmaceuticals worth $67.6K as of Q1 2026.
  • Group One Trading bought 612 Corbus Pharmaceuticals shares in Q1 2026, an estimated $5.15K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5043 holding.
  • Group One Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 32 quarters since.
  • Group One Trading's Corbus Pharmaceuticals position peaked at $966K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.